FDA, CMS Working To Smooth ‘Baton Handoff’ From New Drug Approval To Reimbursement

FDA commissioner Robert Califf wants to develop a postapproval evidence generation system through ongoing collaboration with CMS. Public health experts say efforts by FDA and CMS to work more closely could result in greater clarity on trial designs early in development programs.